Viking Therapeutics Inc (NASDAQ: VKTX): Hunting Genuine Value In Market Debris

Fidelity Management & Research Co recently announced the acquisition of new stake in Viking Therapeutics Inc (NASDAQ:VKTX). The institutional investor has increased its shareholding in the Healthcare company by 0.19% to 14.94 million shares with purchase of 28523.0 shares. This fresh investment now brings its stake to 14.94% valued currently at $182.58 million. In addition, […]

Viking Therapeutics Inc (NASDAQ: VKTX): Analyst View Points To Future Growth

Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $182.58 million. […]

Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?

Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $146.57 million. […]

Now Is A Suitable Moment For A Long-Term Purchase Of Viking Therapeutics Inc (NASDAQ: VKTX)

Fidelity Management & Research Co recently announced the acquisition of new stake in Viking Therapeutics Inc (NASDAQ:VKTX). The institutional investor has increased its shareholding in the Healthcare company by 0.19% to 14.94 million shares with purchase of 28523.0 shares. This fresh investment now brings its stake to 14.94% valued currently at $146.57 million. In addition, […]